Key Highlights
- Anne Beal, MD, MPH joins Omada Health’s Board of Directors.
- Brings expertise from GSK plc, Prolacta Bioscience, and Sanofi.
- Recognized for advancing patient-centered care and innovation.
- Omada Health aims to expand access to virtual care for chronic conditions.
- Focuses on scaling programs for diverse patient populations.
Source: Business Wire
Notable Quotes
- “We believe that her track record on the boards of both public and private companies, combined with her leadership roles at respected life sciences and non-profit organizations, will be a valuable addition to Omada as we scale our programs to serve diverse patient populations and address their evolving care needs.” — Sean Duffy, CEO and Co-Founder at Omada Health
- “I am excited to join Omada’s Board of Directors and contribute to a company that places clinical evidence at the forefront of healthcare innovation.” — Dr. Anne Beal, MD, MPH, Board Member at Omada Health
SoHC's Take
The addition of Dr. Anne Beal to Omada Health’s Board of Directors marks a strategic move as the company continues to expand its virtual-first approach to chronic care management. Her extensive experience in integrating patient voices into healthcare initiatives aligns seamlessly with Omada’s commitment to patient-centered innovation. This move is expected to strengthen Omada’s ability to serve diverse populations, leveraging Dr. Beal’s insights from her roles across leading pharmaceutical and non-profit organizations. The partnership underscores Omada’s drive to deliver personalized care solutions that extend beyond traditional clinical settings, emphasizing a holistic approach to chronic care.
